Stocks · Health care · Pharmaceutical Preparations

Viatris

VTRS Clue Score21
United States Fiscal year ends December CIK 0001792044 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
David S Simmons
3 Nov 2025
Director
Buy indirect
213
$10.43
$2.22K
David S Simmons
27 Aug 2025
Director
Buy indirect
286
$10.42
$2.98K
Scott Andrew Smith
12 Aug 2025
Chief Executive Officer
Buy
22,000
$9.99
$219.74K
Scott Andrew Smith
12 May 2025
Chief Executive Officer
Buy
60,000
$8.94
$536.26K
Harry Korman
26 Oct 2023
Director
Buy
19
$9.01
$171.13
Harry Korman
16 Mar 2022
Director
Buy
239
$10.42
$2.49K
Michael Goettler
15 Mar 2022
Chief Executive Officer
Buy
50,352
$9.87
$496.77K
W Don Cornwell
15 Mar 2022
Director
Buy
2,700
$9.90
$26.72K
Harry Korman
4 Mar 2022
Director
Buy
1,150
$10.08
$11.59K
Harry Korman
16 Dec 2021
Director
Buy
176
$12.84
$2.26K
Harry Korman
16 Sep 2021
Director
Buy
162
$13.81
$2.24K
Harry Korman
16 Jun 2021
Director
Buy
145
$15.39
$2.23K
W Don Cornwell
21 May 2021
Director
Buy
500
$15.45
$7.73K
W Don Cornwell
19 May 2021
Director
Buy
1,500
$15.79
$23.69K
Harry Korman
9 Mar 2021
Director
Buy
349
$13.94
$4.86K
W Don Cornwell
3 Mar 2021
Director
Buy
3,000
$13.84
$41.51K
Harry Korman
25 Feb 2021
Director
Buy
713
$14.97
$10.67K
Harry Korman
15 Jan 2021
Director
Buy
837
$16.99
$14.22K
James M Kilts
16 Dec 2020
Director
Buy
27,736
$17.66
$489.69K
Harry Korman
11 Dec 2020
Director
Buy
613
$17.15
$10.51K

What was left out

Form 4 filings counted 280
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 2
Sales at will 23
Transactions with no price 0
Shares from compensation/vesting 1,394,932,371
Sales filed before the plan box existed 8
History held since 16 Nov 2020